Tectonic Therapeutic, Inc. (TECX) — Stock Score Summary

Tectonic Therapeutic, Inc. (TECX) has a MoatMap StockRank of 58/100 based on Quality (41/100), Value (38/100), and Momentum (64/100) factor scores. The current signal is HOLD. Tectonic Therapeutic is an early-stage biotech lacking revenues or established moats, representing a speculative bet rather than a high-conviction compounder.

Tectonic Therapeutic, Inc. is a biotechnology company focused on discovering and developing G protein-coupled receptor (GPCR)-targeted therapeutics. Leveraging its proprietary GEODe platform, Tectonic aims to create precise and potent modulators for challenging GPCR targets implicated in various diseases. The company operates as a niche, preclinical-stage platform biotech, distinguishing itself through its advanced structural biology and computational approaches to drug discovery.

Key Financial Metrics

Price$28.56
Market Cap$562M
P/E (Forward)-6.22
Price/Book2.38
Return on Equity-31.4%
Return on Invested Capital-29.0%
Debt/Equity2.01
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-45M

Tectonic Therapeutic, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Tectonic Therapeutic, Inc.’s (TECX) StockRank?
MoatMap’s StockRank for Tectonic Therapeutic, Inc. (TECX) is 58/100, with a Hold signal. It is a composite of Quality (41), Value (38), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tectonic Therapeutic, Inc. have an economic moat?
Tectonic Therapeutic, Inc. (TECX) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tectonic Therapeutic, Inc. a buy, hold, or sell?
MoatMap’s current signal for Tectonic Therapeutic, Inc. (TECX) is Hold, based on a StockRank of 58/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tectonic Therapeutic, Inc. in?
Tectonic Therapeutic, Inc. (TECX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksTECX deep dive reportAI ChampionsHow we score stocksSense-check another stock